The pathogenesis of acquired TTP is not fully understood but is believed to be mediated by autoantibodies that block the activity of ADAMTS13 enzyme leaving overactive large von Willebrand factor (vWF) multimers. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.